Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension
Katleen Swinnen(KU Leuven), Marion Delcroix(American Institute of Biological Sciences), Wim Janssens(KU Leuven), Catharina Belge, Jean‐Luc Vachiéry(Erasmus Hospital), Rozenn Quarck(KU Leuven), Claudia Baratto(University of Bergamo), Laura Hardy(KU Leuven), Maarten De Vos(Rega Institute for Medical Research), Kenneth Verstraete(KU Leuven), Guido Claessen, Marko Topalović(University of Kragujevac)
Cited by 13
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k